Combining NBTXR3 with HDXRT, LDXRT, and anti-PD-1/anti-CTLA4 slowed tumor growth, reduced lung metastases, and improved survival, with some mice achieving complete tumor eradication. Here, CTLA4 is linked to neoplasm.